An AAV Dual Vector Strategy Ameliorates the Stargardt Phenotype in Adult Abca4-/- Mice. (2019)
Attributed to:
Developing gene therapy to treat blindness caused by Stargardt Disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1089/hum.2018.156
PubMed Identifier: 30381971
Publication URI: http://europepmc.org/abstract/MED/30381971
Type: Journal Article/Review
Volume: 30
Parent Publication: Human gene therapy
Issue: 5
ISSN: 1043-0342